|
|
| Line 1: |
Line 1: |
| __NOTOC__
| |
| This Wiki is for collaborative creation of QIBA materials and ongoing activities.
| |
|
| |
|
| ='''Quantitative Imaging Biomarkers Alliance (QIBA)'''= | | == Welcome to RxClaim WikiPage == |
| | | [[Media:Example.ogg]] |
| '''QIBA Mission: Improve the value and practicality of quantitative biomarkers by reducing variability across devices, patients and time.'''
| |
| | |
| | |
| QIBA is an initiative to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice by engaging researchers, healthcare professionals and industry . This involves:
| |
| | |
| :* collaborating to identify needs, barriers, and solutions to develop and test consistent, reliable, valid, and achievable quantitative imaging results across imaging platforms, clinical sites, and time.
| |
| :* accelerating the development and adoption of hardware and software standards needed to achieve accurate and reproducible quantitative results from imaging methods.
| |
| | |
| | |
| QIBA develops Profile specifications and coordinates the necessary research and qualification groundwork.
| |
| :* [[What Are Profiles?]]
| |
| :* [[Media:Profiling.ppt|How Does QIBA Derive Profiles?]]
| |
| | |
| ==QIBA Committees==
| |
| QIBA currently has four active committees:
| |
| :* [[Quantitative-MRI]]
| |
| :**[[DCE-MRI subctte]]
| |
| :**[[fMRI subctte]]
| |
| :* [[Quantitative-PET]]
| |
| :* [[Quantitative-CT]]
| |
| :* [[COPD-Asthma]]
| |
| | |
| ==Documents==
| |
| *[[Media:QIBA Round-1 Projects Overview.pdf|QIBA Round-1 Funded Projects Overview]]
| |
| *[[Media:HHSN268201000050C_QIBA_Semiannual_Report_3-11-2010.doc|QIBA 1H-FY2011 Semi-annual Report (2011.03.11)]]
| |
| *[[Media:Why_QIBA_CT_specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
| |
| *[[Media:Why_QIBA_PET-CT_specifics.pdf|"Why QIBA?" - Specifics associated with PET-CT device and software manufacturers.]]
| |
| *[[Media:Why_QIBA_MR_specifics.pdf|"Why QIBA?" - Specifics associated with MR device and software manufacturers.]]
| |
| *[[Media:HHSN268201000050C_QIBA_Proposed_Workplan_11-22-2010.doc|QIBA Work Plan (2010.11.22)]]
| |
| *[[QIBA and UPICT posters from RSNA 2010 Annual Meeting]]
| |
| *[[QIBA and UPICT posters from RSNA 2009 Annual Meeting]]
| |
| *[[Media:EU.2009.08.04 Guideline on Clinical evaluation of diagnostic agents.pdf|EMEA Guideline on Clinical Evaluation of Diagnostic Agents (2009.08.04)]]
| |
| *[[Media:EU.2009.08.04 Appendix 1 to the guideline.pdf|EMEA Guideline - Appendix 1 (2009.08.04)]]
| |
| *[[Media:Oncology section.ppt|Oncology section from 2009 Imaging Biomarkers Roundtable]]
| |
| *[[Media:FREEMAN_FINAL_PROOF.pdf|QIBA posters from RSNA 2008 Annual Meeting]]
| |
| | |
| ==Ad Hoc Committees==
| |
| :*[[Committee on Open Image Archives]]
| |
| | |
| ----
| |
| | |
| ==Quantitative Imaging/Imaging Biomarkers and QIBA Meetings and Activities==
| |
| *QI/IB Special Interest Session-
| |
| Imaging Biomarkers for Clinical Care and Research
| |
| Monday, November 29, 2010
| |
| '''[http://www2.rsna.org/re/QI_IB_Special_Interest_Session_RSNA_2010/Index.htm Presentations]'''
| |
| | |
| *QIBA Annual Meeting Presentations
| |
| May 24-25, 2011
| |
| Renaissance Arlington Capital View, Arlington VA
| |
| '''[http://www2.rsna.org/re/QIBA_Annual_Meeting_2011/ Presentations]'''
| |
| | |
| | |
| ----
| |
| | |
| NEW: '''[[How To's| "How To" help pages]]'''
| |
| | |
| *[[Media:Enabling E-alerts-20100504.pdf|Enabling E-alerts]]
| |
| | |
| *[[Media:Microsoft Word - WIKI PROTOCOL-v2.pdf|Posting Material]]
| |
| | |
| *[[Media:Wiki Help-History Overview2.pdf|History Search]]
| |
| | |
| '''''<This Wiki is a Work In Progress: read [[Help:Contents|Help]], create an [[Wiki Accounts|account]], contribute>'''''
| |